TRPV1 Antagonists and Chronic Pain: Beyond Thermal Perception

In the last decade, considerable evidence as accumulated to support the development of Transient Receptor Potential Vanilloid 1 (TRPV1) antagonists for the treatment of various chronic pain conditions. Whereas there is a widely accepted rationale for the development of TRPV1 antagonists for the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandt, Michael R., Beyer, Chad E., Stahl, Stephen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763634/
https://www.ncbi.nlm.nih.gov/pubmed/24288084
http://dx.doi.org/10.3390/ph5020114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763634/
https://www.ncbi.nlm.nih.gov/pubmed/24288084
http://dx.doi.org/10.3390/ph5020114

Ejemplares similares